Viewing data from:

CHLOROQUINE PHOSPHATE

ANDA

CHLOROQUINE PHOSPHATE | A080880 | IMPAX LABORATORIES INC

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 1 NDC

Highest NADAC/Unit

$2.68

per ea

Lowest NADAC/Unit

$2.68

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
00115279006CHLOROQUINE PH 250 MG TABLET	$2.68	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain3 active DMFs1 inactive

3 active API suppliers hold Drug Master Files for this ingredient.

IPCA LABORATORIES LTDCHLOROQUINE PHOSPHATE USP

DMF 92351991

NATCO PHARMA LTDCHLOROQUINE PHOSPHATE

DMF 330672019

COHANCE LIFESCIENCES LTDCHLOROQUINE PHOSPHATE USP

DMF 341302019

ICN HUNGARY CO LTDInactiveCHLOROQUINE PHOSPHATE

DMF 104721993

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 250MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Approved Prior to Jan 1, 1982

No patent or exclusivity listings for this strength.